What eubioco does

Eubioco is a Polish Contract Development and Manufacturing Organization (CDMO) headquartered in Warsaw, with a GMP-certified production facility — Galenic Laboratory Olsztyn (LGO) — serving as its core operating subsidiary. Founded around 1991, the company operates for over 30 years in pharmaceutical, dietary supplement, cosmetic, medical device, and animal supplement contract manufacturing. Production forms span tablets, hard capsules (gelatin, HPMC, pullulan, liquid-filled), sachets, gels, and liquids, with proprietary Eubiocap capsule-in-capsule technology enabling staged release of incompatible ingredients such as omega-3 oils in dry powder matrices.

The company runs in-house physical-chemical and microbiological quality control laboratories equipped with HPLC, UV/VIS, FT-NIR/IR spectrometers, and stability chambers, supported by ARIEL and EPIONE process documentation and traceability systems. Service scope is end-to-end: R&D formulation, raw material qualification, GMP-certified production, packaging (blisters, sachets, tubes), labeling compliance, regulatory documentation (GIS, CPNP, EUDAMED, MDR 2017/745), and GDP-compliant warehousing and distribution.

Eubioco's commercial model is B2B enterprise contract manufacturing: project-based professional services engagements with minimum order quantities of 150,000 units for hard capsules and 75,000 units for sachets. Go-to-market relies on direct sales via dedicated email channels ([email protected], [email protected], [email protected]), an extensive technical content/knowledge base, multilingual website presence (Polish, English, German), and participation in major industry trade shows including CPHI Frankfurt 2025 and Vitafoods Europe/Barcelona. The company holds GMP certification valid through 2028, ISO 22000:2018, ISO 22716, and HACCP, and serves a named enterprise customer base of 17+ Polish pharmaceutical, cosmetics, and health/wellness companies including Polfarmex, Herbapol, Neuca, Synoptis, Swiss Pharm, Medicare, Dino, and Cosmedica.

Name

eubioco

Legal name

EUBIOCO Spółka z ograniczoną odpowiedzialnością

Website

https://eubioco.eu

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Eubioco is a Polish CDMO providing end-to-end contract development, manufacturing, and regulatory services for pharmaceuticals, dietary supplements, cosmetics, and medical devices via its GMP-certified Galenic Laboratory Olsztyn facility, serving enterprise B2B clients across European markets.

Ownership category

akta.pro rank

Headquarters

HQ city

Litzmannstadt

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Full-service contract development and manufacturing organization (CDMO) providing end-to-end services from R&D formulation and regulatory support through production and quality control to packaging, warehousing, and distribution (GDP-compliant). Revenue generated through project-based manufacturing contracts for pharmaceuticals, dietary supplements, cosmetics, and medical devices. Services include GMP-certified manufacturing, regulatory registration support, and quality documentation.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Eubioco is a Polish Contract Development and Manufacturing Organization (CDMO) providing end-to-end services from R&D formulation and regulatory documentation through GMP-certified production, quality control, packaging, and GDP-compliant distribution of medicines, dietary supplements, cosmetics, medical devices, and animal supplements. Production is executed at its GMP-certified Galenic Laboratory Olsztyn facility across dosage forms including tablets, hard capsules (gelatin, HPMC, pullulan, including liquid-filled), sachets, gels, and liquids. A proprietary Eubiocap capsule-in-capsule technology enables staged release and physical separation of incompatible ingredients such as omega-3 oils and dry powders.

Product overview

Eubioco is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end manufacturing services for the pharmaceutical, dietary supplement, cosmetics, and medical device industries. The portfolio centers on contract manufacturing of medicines, supplements, and cosmetics, supported by the Galenic Laboratory Olsztyn facility. Production forms include tablets, hard capsules (with gelatin, HPMC, and pullulan variants), sachets, gels, and liquids. The company's proprietary Eubiocap capsule-in-capsule technology enables staged release and protection of incompatible ingredients. Additional services encompass regulatory support, quality control (HPLC, UV/VIS, FT-NIR/IR analysis), stability testing, and packaging/conification. Products are available for White Label production through their catalog.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services (CDMO) End-to-end contract development and manufacturing services for medicinal products (Rx and OTC), dietary supplements, cosmetics, animal supplements, and medical devices, delivered under GMP standards and including regulatory documentation, EUDAMED/GIS/CPNP notification support, serialization, packaging, and GDP-compliant distribution.
• Eubiocap (Capsule-in-Capsule Technology) Proprietary capsule-in-capsule technology that physically separates incompatible ingredients by placing a smaller capsule (typically containing liquid or oil-based lipophilic form such as omega-3 fatty acids) inside a larger capsule containing stable dry form (powder, granules, or pellets), with a sealing band at the cap-body junction. Enables staged release of ingredients in sequence and protects sensitive substances.
• Tablets Solid dosage form production including round, oblong, and coated tablets for pharmaceutical and dietary supplement applications, produced under GMP.
• Hard Capsules (including Liquid-Filled Hard Capsules / LFHC) Two-piece hard capsules in gelatin, HPMC, and pullulan variants for powder, granule, and pellet fills, including liquid-filled hard capsules (LFHC) for encapsulating liquids, suspensions, and semi-solid formulations. Protects moisture-, oxygen-, and temperature-sensitive substances and increases bioavailability of poorly soluble active ingredients.
• Sachets Single-dose sachet packaging for powders and granulates, produced on the Effytec HB-14 packaging line for precision and speed; supports dietary supplements and pharmaceutical applications.
• Gels Gel formulations for topical or oral delivery of active ingredients, produced under GMP for pharmaceutical and supplement applications.
• Liquids Liquid dosage forms including solutions, syrups, and drops for pharmaceutical and supplement applications, produced under GMP.
• Galenic Laboratory Olsztyn (GMP-certified laboratory facility) Wholly-owned GMP-certified pharmaceutical and supplement manufacturing laboratory providing analytical services, stability testing, physical-chemical and microbiological testing, and R&D support for product development. Holds GMP certification (valid until 2028) and ISO 22000:2018 (December 2024).
• Product Catalog (White Label / Private Label) Catalog of finished-formulation products across cosmetics, medicinal products, medical devices, dietary supplements, packaging materials, tablets and capsules, and pharmaceutical raw materials available for White Label / private label production by brand customers.
• Regulatory Support Services Full regulatory documentation support including GIS notifications (dietary supplements), CPNP notifications (cosmetics), EUDAMED registration (medical devices/pharma), and MDR 2017/745 compliance for medical devices, bundled with contract manufacturing engagements.

Quantifiable outcome

• 35+ years of industry experience
• +3 more outcomes

Named customers17 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered minor.

• Science Pharma Spółka z ograniczoną odpowiedzialnością Spółka KomandytowaminorOthersEntity cooperating with EUBIOCO as data processor for receiving, analyzing, archiving, and processing reports of adverse effects (drug safety monitoring). Located at ul. Chełmska 30/34, 00-725 Warsaw. Personal data shared with this partner is subject to mandatory anonymization.
• Rapofarm Kamil RupietaminorOthersEntity cooperating with EUBIOCO as data processor for receiving, analyzing, archiving, and processing reports of adverse effects (drug safety monitoring). Located at ul. Kazimierza Górskiego 3, 97-400 Bełchatów. Personal data shared with this partner is subject to mandatory anonymization.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Siegfried Holding: Swiss-listed CDMO offering API manufacturing and finished dosage form services (tablets, capsules, sterile) to global pharma companies. Comparable to eubioco as a European CDMO serving pharma brands, though at much larger scale and with deeper API capabilities.
• Hovione: Portuguese CDMO specializing in oral dosage forms, inhalation, and API development for global pharma. Comparable to eubioco as a European mid-to-large CDMO serving pharma customers across solid dosage forms.
• Recipharm: Swedish-headquartered European CDMO offering contract manufacturing of oral solids, sterile injectables, and other dosage forms to pharma and consumer health companies. Highly comparable to eubioco as a multi-modality European CDMO serving pharma and consumer health brands, though at significantly larger scale.
• Aenova Group: German CDMO specializing in solid dosage forms (tablets, capsules), semi-solids, liquids, and sterile products for pharma and consumer health. Comparable to eubioco as a European contract manufacturer serving pharma and supplement brands across multiple dosage forms.

Broad incumbents

• Catalent: Global CDMO offering softgel/hard-capsule, tablet, sachet, and oral dose manufacturing for pharma and consumer health. Comparable to eubioco in the capsule/sachet/tablet CDMO space, but operates at vastly larger scale and with broader geographic coverage.

Regional players

• Polpharma Group: Largest Polish pharmaceutical manufacturer with its own CDMO offering. Comparable to eubioco as a Polish pharma manufacturing player, though primarily a brand owner rather than a pure-play CDMO and significantly larger.
• Adamed Pharma: Polish pharma company with manufacturing of finished dosage forms (tablets, capsules) for pharma and supplement markets. Comparable to eubioco as a Polish manufacturer serving pharma and consumer health customers, though also a brand owner rather than pure CDMO.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/eubioco
• LinkedInlinkedin.com/company/eubioco

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eubioco